Skip to content

Clinical Application Evaluation of High Energy Focused Ultrasound in the Treatment of Adenomyosis

Clinical Application Evaluation of High Energy Focused Ultrasound in the Treatment of Adenomyosis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-PNC-16009873
Enrollment
Unknown
Registered
2016-11-15
Start date
2016-11-20
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adenomyosis

Interventions

surgery group:Excision of adenomyosis
HIFU group:High Energy Focused Ultrasound

Sponsors

Shanghai First Maternity and Infant Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
25 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. adenomyosis diagnosis is clear, there are indications for surgery: (1) Uterine enlargement; (2) Menorrhagia, secondary to anemia; (3) Have dysmenorrhea, oppression symptoms; 2. no contraindications for surgery and anesthesia; 3. preoperative examination is complete; 4. consent of patients and their families agree; 5. other conditions to be met: (1) Premenopausal women; (2) Married already educated; (3) Transvaginal ultrasound or MRI examination showed adenomyosis; (4) Diagnostic ultrasound by abdominal scanning, no significant acoustic attenuation (more than 10mm range).

Exclusion criteria

Exclusion criteria: 1. Having a number of surgical history, including the abdomen, by laparoscopy, hysteroscopy, localization, check the acoustic channel abnormalities; 2. a history of collagen connective tissue, or radiotherapy history, especially the history of abdominal radiotherapy; 3. pregnancy, genital tract acute inflammation, or combined with other gynecological benign and malignant diseases such as endometriosis, ovarian cancer patients; 4. cervical adenomyosis; 5. the largest diameter of adenomyosis greater than 10cm, blood supply, tumor markers abnormalities, suspicious malignant transformation; 6. language barriers, can not cope with sedative analgesia.

Design outcomes

Primary

MeasureTime frame
Uterine volume reduction rate;Quality of Life;dysmenorrhea symptoms;Visual analog scale;The rate of uterine volume reduction;

Secondary

MeasureTime frame
Sexual function;

Countries

China

Contacts

Public ContactAili.Aixingzi

Shanghai First Maternity and Infant Hospital

1819483078@qq.com+86 18017211589

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026